Companies Dominating the Transcriptomics Technologies Landscape
- Danaher Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche AG
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- Pacific Bioscience of California, Inc.
- BioSkryb Genomics
- Agilent Technologies Inc.
- Parse Biosciences
Browse Key Market Insights with Data Illustration:
In the News
- May 2022: Launching Early Access Program (EAP) for ResolveOME, a unified single-cell workflow that amplifies the entire transcriptome and genome from the same cell. BioSkryb Genomics is a biotech company that develops advanced single-cell analysis tools. The necessity to divide up the source material or analyze different datasets was removed by this unification. Applications for the EAP will be accepted from businesses and researchers at the Advances in Genome Biology and Technology (AGBT) 2022 General Meeting, which will be held in Orlando from June 6–9. First access to BaseJumperTM, a bioinformatics platform for sorting, analyzing, and interpreting very large single-cell analysis data sets, and BioSkryb's ResolveOME technology will be granted through the EAP.
- January 2022: Parse Biosciences, a company that offers single-cell sequencing solutions to researchers, announced a partnership with Research Instruments Pte Ltd to supply Parse's Nuclei Fixation Kits, Cell Fixation Kits, and Evercode Whole Transcriptome Kits (WTKs) to Southeast Asian and Singaporean markets. As per the mutual agreement, Research Instruments has been designated as the distributor for Singapore, Thailand, Malaysia, and Vietnam of the Parse product line.
